Quick Takeaways
- BHVN - Biohaven Ltd. has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: +$33,144,763.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders: BHVN, BHVN
Insider Transactions Reported by 13 Insiders of Biohaven Ltd.
- Symbol
- BHVN on NYSE
- Location
- New Haven, CT
What Changed
- Buy value: $33,144,763; sell value: $0.
- Net share flow: +4,416,999.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$33,144,763.
Buys
$33,144,763
Shares: 4,416,999
Insiders: 4
Sells
$0
Shares: 0
Insiders: 0
Net
+$33,144,763
Shares: +4,416,999
Insiders: 4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 4,416,999 | 0 | $33,144,763 | $0 | +$33,144,763 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Biohaven Ltd. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John W. Childs | Director | $71,551,991 | +$24,999,998 | +54% | Mixed | 13 Nov 2025 |
| Vlad Coric | Chief Executive Officer, Director | $41,005,808 | +$4,999,995 | +14% | Mixed | 27 Feb 2026 |
| Gregory H. Bailey | Director | $15,150,532 | +$3,000,000 | +25% | Filing P/S | 13 Nov 2025 |
| Matthew Buten | Chief Financial Officer | $1,942,824 | Mixed | 27 Feb 2026 | ||
| Kimberly Gentile | SVP, Clinical Operations | $988,601 | Mixed | 27 Feb 2026 | ||
| George C. Clark | VP, Chief Accounting Officer | $890,891 | +$144,770 | +19% | Mixed | 27 Feb 2026 |
| Bruce Car | Chief Scientific Officer | $415,309 | Mixed | 27 Feb 2026 | ||
| Kishan Mehta | Director | $260,613 | Market | 17 Mar 2026 | ||
| Biohaven Pharmaceutical Holding Co Ltd. | 10%+ Owner | Mixed | 03 Oct 2022 | |||
| Irina Antonijevic | Director | Mixed | 05 May 2025 | |||
| Robert J. Hugin | Director | Mixed | 05 May 2025 | |||
| Julia P. Gregory | Director | Mixed | 05 May 2025 | |||
| Michael Thomas Heffernan | Director | Mixed | 05 May 2025 |
Top shareholders of Biohaven Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
13%
|
16,803,459
|
$189,711,052 | +$113,253,896 | 30 Jan 2026 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
13D/G
|
Company |
7.8%
from 13D/G
|
10,286,937
|
$116,139,519 | — | 31 Dec 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
7.5%
|
9,939,856
|
$112,220,980 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.2%
|
9,448,040
|
$106,668,371 | — | 31 Dec 2025 | |
| John W. Childs |
3/4/5
|
Director |
—
mixed-class rows
|
2,428,857
mixed-class rows
|
$71,551,991 | +$24,999,998 | 13 Nov 2025 | |
| INFINITUM ASSET MANAGEMENT, LLC |
13F
|
Company |
4.7%
|
6,250,000
|
$70,562,500 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
5,716,487
|
$64,539,138 | — | 31 Dec 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
3.5%
|
4,631,317
|
$52,287,569 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
2.7%
from 13D/G
|
4,395,946
|
$49,630,230 | — | 31 Dec 2025 | |
| Vlad Coric |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
4,427,854
mixed-class rows
|
$41,005,808 | +$4,999,995 | 27 Feb 2026 | |
| Royalty Pharma Sub-Manager, LLC |
13F
|
Company |
2.2%
|
2,936,507
|
$33,153,164 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2%
|
2,694,234
|
$30,417,901 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
2%
|
2,682,234
|
$30,282,423 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,392,277
|
$27,014,387 | — | 31 Dec 2025 | |
| Knoll Capital Management, LLC |
13F
|
Company |
—
class O/S missing
|
2,328,602
|
$26,289,916 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1.6%
|
2,093,816
|
$23,639,183 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
2,018,550
|
$22,790,000 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
1,962,206
|
$22,153,306 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
1,792,443
|
$20,236,682 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.3%
|
1,743,993
|
$19,689,681 | — | 31 Dec 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.2%
|
1,606,777
|
$18,140,510 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.2%
|
1,591,054
|
$17,963,000 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.2%
|
1,570,610
|
$17,732,187 | — | 31 Dec 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.1%
|
1,500,000
|
$16,935,000 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,460,108
|
$16,484,619 | — | 31 Dec 2025 | |
| Gregory H. Bailey |
3/4/5
|
Director |
—
mixed-class rows
|
2,051,787
mixed-class rows
|
$15,150,532 | +$3,000,000 | 13 Nov 2025 | |
| Capital Research Global Investors |
13F
|
Company |
1%
|
1,332,792
|
$15,047,222 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
1,324,247
|
$14,950,749 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1%
|
1,318,775
|
$14,888,970 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.95%
|
1,259,031
|
$14,214,460 | — | 31 Dec 2025 | |
| MYDA Advisors LLC |
13F
|
Company |
0.95%
|
1,250,000
|
$14,112,500 | — | 31 Dec 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.94%
|
1,244,764
|
$14,053,386 | — | 31 Dec 2025 | |
| ARS Investment Partners, LLC |
13F
|
Company |
0.94%
|
1,239,600
|
$13,995,084 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.9%
|
1,192,026
|
$13,457,974 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.9%
|
1,188,358
|
$13,416,562 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
975,196
|
$11,009,968 | — | 31 Dec 2025 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.73%
|
958,336
|
$10,819,613 | — | 31 Dec 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.73%
|
958,202
|
$10,818,101 | — | 31 Dec 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.72%
|
955,235
|
$10,784,603 | — | 31 Dec 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.65%
|
854,424
|
$9,646,447 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
847,412
|
$9,567,281 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
840,285
|
$9,486,817 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.64%
|
839,517
|
$9,478,147 | — | 31 Dec 2025 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.59%
|
772,181
|
$8,717,923 | — | 31 Dec 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.56%
|
738,972
|
$8,342,994 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.55%
|
731,953
|
$8,263,744 | — | 31 Dec 2025 | |
| Fiera Capital Corp |
13F
|
Company |
0.55%
|
724,551
|
$8,180,180 | — | 31 Dec 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.53%
|
702,884
|
$7,935,560 | — | 31 Dec 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.53%
|
693,300
|
$7,850,682 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.53%
|
693,452
|
$7,829,073 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Biohaven Ltd.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Kishan Mehta | BHVN | Common Shares | Gift | 17,342 | 17,342 | 17 Mar 2026 | By Kishen Mehta 21 Family Irrevocable Trust | |||
| Kishan Mehta | BHVN | Common Shares | Gift | -76.5% | -17,342 | 5,320 | 17 Mar 2026 | Direct | ||
| Matthew Buten | BHVN | Stock Options (Right to buy) | Award | 175,000 | 175,000 | 27 Feb 2026 | Direct | |||
| Kimberly Gentile | BHVN | Stock Options (Right to buy) | Award | 175,000 | 175,000 | 27 Feb 2026 | Direct | |||
| George C. Clark | BHVN | Stock Options (Right to buy) | Award | 50,000 | 50,000 | 27 Feb 2026 | Direct | |||
| Bruce Car | BHVN | Stock Options (Right to buy) | Award | 175,000 | 175,000 | 27 Feb 2026 | Direct | |||
| Vlad Coric | BHVN | Stock Options (Right to buy) | Award | 550,000 | 550,000 | 27 Feb 2026 | Direct | |||
| Kimberly Gentile | BHVN | Common Shares | Tax liability | -1.93% | -1,956 | 99,557 | 05 Jan 2026 | Direct | ||
| Kimberly Gentile | BHVN | Common Shares | Options Exercise | 3.84% | 3,750 | 101,513 | 05 Jan 2026 | Direct | ||
| Kimberly Gentile | BHVN | Restricted Share Unit Award | Options Exercise | -33.3% | -3,750 | 7,500 | 05 Jan 2026 | Direct | ||
| Matthew Buten | BHVN | Common Shares | Tax liability | -1.31% | -2,594 | 195,652 | 05 Jan 2026 | Direct | ||
| Matthew Buten | BHVN | Common Shares | Options Exercise | 2.19% | 4,250 | 198,246 | 05 Jan 2026 | Direct | ||
| Matthew Buten | BHVN | Restricted Share Unit Award | Options Exercise | -33.3% | -4,250 | 8,500 | 05 Jan 2026 | Direct | ||
| Vlad Coric | BHVN | Common Shares | Tax liability | -0.41% | -7,430 | 1,803,968 | 05 Jan 2026 | Direct | ||
| Vlad Coric | BHVN | Common Shares | Options Exercise | 0.79% | 14,250 | 1,811,398 | 05 Jan 2026 | Direct | ||
| Vlad Coric | BHVN | Restricted Share Unit Award | Options Exercise | -33.3% | -14,250 | 28,500 | 05 Jan 2026 | Direct | ||
| Bruce Car | BHVN | Common Shares | Tax liability | -23.6% | -2,381 | 7,715 | 05 Jan 2026 | Direct | ||
| Bruce Car | BHVN | Common Shares | Options Exercise | 88.8% | 4,750 | 10,096 | 05 Jan 2026 | Direct | ||
| Bruce Car | BHVN | Restricted Share Unit Award | Options Exercise | -33.3% | -4,750 | 9,500 | 05 Jan 2026 | Direct | ||
| George C. Clark | BHVN | Common Shares | Tax liability | -1.64% | -1,117 | 66,978 | 05 Jan 2026 | Direct | ||
| George C. Clark | BHVN | Common Shares | Options Exercise | 3.81% | 2,500 | 68,095 | 05 Jan 2026 | Direct | ||
| George C. Clark | BHVN | Restricted Share Unit Award | Options Exercise | -33.3% | -2,500 | 5,000 | 05 Jan 2026 | Direct | ||
| George C. Clark | BHVN | Common Shares | Purchase | 566.7% | $144,770 | $8.52 | 17,000 | 20,000 | 17 Nov 2025 | By IRA |
| Gregory Bailey | BHVN | Common Shares | Purchase | 24.7% | $3,000,000 | $7.50 | 400,000 | 2,020,071 | 13 Nov 2025 | Direct |
| John W. Childs | BHVN | Common Shares | Purchase | 143.6% | $24,999,998 | $7.50 | 3,333,333 | 5,653,904 | 13 Nov 2025 | By John W Childs 2013 Revocable Trust |
| Vlad Coric | BHVN | Common Shares | Purchase | 81.9% | $2,499,998 | $7.50 | 333,333 | 740,546 | 13 Nov 2025 | By: The Vladimir Coric Marital Trust |
| Vlad Coric | BHVN | Common Shares | Purchase | 38.7% | $2,499,998 | $7.50 | 333,333 | 1,195,275 | 13 Nov 2025 | By: The Vlad Coric Family Trust |
| Irina Antonijevic | BHVN | Stock Options (Right to buy) | Award | 31,716 | 31,716 | 05 May 2025 | Direct | |||
| Michael Thomas Heffernan | BHVN | Stock Options (Right to buy) | Award | 31,716 | 31,716 | 05 May 2025 | Direct | |||
| Gregory Bailey | BHVN | Stock Options (Right to buy) | Award | 31,716 | 31,716 | 05 May 2025 | Direct | |||
| Kishan Mehta | BHVN | Stock Options (Right to buy) | Award | 31,716 | 31,716 | 05 May 2025 | Direct | |||
| Julia P. Gregory | BHVN | Stock Options (Right to buy) | Award | 31,716 | 31,716 | 05 May 2025 | Direct | |||
| John W. Childs | BHVN | Stock Options (Right to buy) | Award | 31,716 | 31,716 | 05 May 2025 | Direct | |||
| Robert J. Hugin | BHVN | Stock Options (Right to buy) | Award | 31,716 | 31,716 | 05 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.